Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...
A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
A team led by Molly Shoichet, a professor in the department of chemical engineering and applied chemistry and the Institute ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently ...
Su Jin Yim and colleagues argue that with the proposed definition of Alzheimer’s disease (AD) expanding in the most recent ...
The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback